A monthly injection of an experimental drug made by the U.S. biotech firm Amgen reduced patients’ cholesterol by up to 66 percent, according to a small study described at a U.S. cardiology conference. Among trial subjects were already taking high doses of cholesterol-lowering drugs, known as statins, and who got the shot every two weeks, the dangerous type of cholesterol (LDL) in their bodies dropped by an average of 63 percent by the eighth week. Those who were on low doses of statins and received the drug every four weeks saw a slightly higher average drop in LDL cholesterol — 66 percent by the end of the same time period
Tag Archives: U.S. biotech firm Amgen
Monthly shot lowers cholesterol 66 percent: study
A monthly injection of an experimental drug made by the U.S. biotech firm Amgen reduced patients’ cholesterol by up to 66 percent, according to a small study described at a U.S. cardiology conference. Among trial subjects were already taking high doses of cholesterol-lowering drugs, known as statins, and who got the shot every two weeks, the dangerous type of cholesterol (LDL) in their bodies dropped by an average of 63 percent by the eighth week. Those who were on low doses of statins and received the drug every four weeks saw a slightly higher average drop in LDL cholesterol — 66 percent by the end of the same time period
BeetAlzain الكويت بيت الزين 